Education
About Us
Working with TipRanks
Follow Us
bioMerieux SA (GB:0RUG)
:0RUG
0RUG Stock Chart & Stats
Day’s Range― - ―
52-Week Range€95.60 - €127.30
Previous CloseN/A
Volume49.49K
Average Volume (3M)46.32K
Market Cap
€14.79B
Enterprise Value€12.36B
Total Cash (Recent Filing)€449.80M
Total Debt (Recent Filing)€490.70M
Price to Earnings (P/E)34.2
Beta0.72
Next Earnings
Sep 04, 2025EPS Estimate
2.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.84
Shares Outstanding118,361,220
10 Day Avg. Volume42,570
30 Day Avg. Volume46,316
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€127.50Price Target Upside1.82% Upside
Rating ConsensusHold
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
EarningsOrganic growth for the quarter was 10.3% vs 8.4% for consensus.
Financial GuidanceGuidance was lifted from 6-8% to 8-10% organic sales growth for the full year.
Bears Say
Product PerformanceBIOFIRE installed base growth slowdown may be debated.
bioMerieux News
0RUG FAQ
What was bioMerieux SA’s price range in the past 12 months?
bioMerieux SA lowest share price was €95.60 and its highest was €127.30 in the past 12 months.
What is bioMerieux SA’s market cap?
bioMerieux SA’s market cap is €14.79B.
When is bioMerieux SA’s upcoming earnings report date?
bioMerieux SA’s upcoming earnings report date is Sep 04, 2025 which is in 22 days.
How were bioMerieux SA’s earnings last quarter?
bioMerieux SA released its earnings results on Mar 07, 2025. The company reported €1.839 earnings per share for the quarter, missing the consensus estimate of €2.15 by -€0.311.
Is bioMerieux SA overvalued?
According to Wall Street analysts bioMerieux SA’s price is currently Undervalued.
Does bioMerieux SA pay dividends?
bioMerieux SA does not currently pay dividends.
What is bioMerieux SA’s EPS estimate?
bioMerieux SA’s EPS estimate is 2.16.
How many shares outstanding does bioMerieux SA have?
bioMerieux SA has 118,361,220 shares outstanding.
What happened to bioMerieux SA’s price movement after its last earnings report?
bioMerieux SA reported an EPS of €1.839 in its last earnings report, missing expectations of €2.15. Following the earnings report the stock price went up 0.177%.
Which hedge fund is a major shareholder of bioMerieux SA?
Currently, no hedge funds are holding shares in GB:0RUG
Company Description
bioMerieux SA
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
0RUG Stock 12 Month Forecast
Average Price Target
€127.50
▲(1.82% Upside)
Technical Analysis
Eurofins Scientific
―
Sartorius Stedim Biotech
―
Sanofi
―
Eurobio-Scientific SA
―
Biosynex SA
―
Ownership Overview
―
Insiders
2.95%
Mutual Funds
<0.01% Other Institutional Investors
93.35% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---